Pfizer and Biontech to Submit Emergency Use Authorization Request Yesterday to the U.S. FDA for COVID-19 Vaccine

New York & Mainz, Germany–(BUSINESS WIRE)– Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced they will submit a request today to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of their mRNA vaccine candidate, BNT162b2 against SARS-CoV-2, which will potentially enable use of the vaccine in high-risk populations in the U.S. by […]

FDA Authorizes Drug Combination for Treatment of COVID-19

FDA Authorizes Drug Combination for Treatment of COVID-19

Washington, DC…The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the drug baricitinib, in combination with remdesivir, for the treatment of suspected or laboratory confirmed COVID-19 in hospitalized adults and pediatric patients two years of age or older requiring supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO). In a clinical […]

Covid Update from Vice President Pence and Members of the Coronavirus Task Force

Covid Update from Vice President Pence and Members of the Coronavirus Task Force

Washington, DC…Well, good afternoon. We just completed our second meeting this week with members of the White House Coronavirus Task Force. And we’ve continued — we’ve continued to be on the same mission we’ve been on throughout the course of this year, and that is to save American lives and to work every day toward […]

COVID-19 Vaccine Candidate Found to be More than 90% Effective in Preventing COVID-19

COVID-19 Vaccine Candidate Found to be More than 90% Effective in Preventing COVID-19

New York, NY & Mainz, DE– Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against COVID-19 in participants without prior evidence of SARS-CoV-2 infection, based on the first interim efficacy analysis conducted on November 8, 2020 by an external, independent Data Monitoring Committee […]

FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine

FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine

Washington, DC…Today, the U.S. Food and Drug Administration (FDA) revoked the emergency use authorization (EUA) that allowed for chloroquine phosphate and hydroxychloroquine sulfate donated to the Strategic National Stockpile to be used to treat certain hospitalized patients with COVID-19 when a clinical trial was unavailable, or participation in a clinical trial was not feasible. The agency determined […]

CDC Releases Recommendations Declaring Communities of Faith Essential

CDC Releases Recommendations Declaring Communities of Faith Essential

Atlanta, GA…Across America, states and localities are experiencing different stages of the COVID-19 pandemic. Many state and local officials have determined to begin moving gradually and strategically toward reopening their regions. Today, CDC published guidance to help prevent exposures to COVID-19 in facilities used by communities of faith and to keep their staff and attendees […]

FDA Authorizes First Antigen Test to Help in the Rapid Detection of the Virus that Causes COVID-19 in Patients

FDA Authorizes First Antigen Test to Help in the Rapid Detection of the Virus that Causes COVID-19 in Patients

White Oak, MD…The U.S. Food and Drug Administration has issued the first emergency use authorization (EUA) for a COVID-19 antigen test, a new category of tests for use in the ongoing pandemic. These diagnostic tests quickly detect fragments of proteins found on or within the virus by testing samples collected from the nasal cavity using swabs. The […]

NIH Clinical Trial Shows Remdesivir Accelerates Recovery from Advanced COVID-19

NIH Clinical Trial Shows Remdesivir Accelerates Recovery from Advanced COVID-19

Bethesda, MD…Hospitalized patients with advanced COVID-19 and lung involvement who received remdesivir recovered faster than similar patients who received placebo, according to a preliminary data analysis from a randomized, controlled trial involving 1063 patients, which began on February 21. The trial (known as the Adaptive COVID-19 Treatment Trial, or ACTT), sponsored by the National Institute […]

ACEP-AAEM Issue Joint Statement on Physician Misinformation as Consensus in Medical Community Breaks Down

ACEP-AAEM Issue Joint Statement on Physician Misinformation as Consensus in Medical Community Breaks Down

Irving, TX & Milwaukee, WI…The American College of Emergency Physicians (ACEP) and the American Academy of Emergency Medicine (AAEM) jointly and emphatically condemn the recent opinions released by Dr. Daniel Erickson and Dr. Artin Massihi. These reckless and untested musings do not speak for medical societies and are inconsistent with current science and epidemiology regarding […]

Lysol Maker Warns on Injection, Ingestion or Other Improper use of Disinfectants

Lysol Maker Warns on Injection, Ingestion or Other Improper use of Disinfectants

Parsippany, NJ…Due to recent speculation and social media activity, RB (the makers of Lysol and Dettol) has been asked whether internal administration of disinfectants may be appropriate for investigation or use as a treatment for coronavirus (SARS-CoV-2). As a global leader in health and hygiene products, we must be clear that under no circumstance should our disinfectant […]

1 2 3 5